115 related articles for article (PubMed ID: 34402091)
1. Direct platelet adhesion potentiates group 2 innate lymphoid cell functions.
Orimo K; Tamari M; Takeda T; Kubo T; Rückert B; Motomura K; Sugiyama H; Yamada A; Saito K; Arae K; Kuriyama M; Hara M; Soyka MB; Ikutani M; Yamaguchi S; Morimoto N; Nakabayashi K; Hata K; Matsuda A; Akdis CA; Sudo K; Saito H; Nakae S; Tamaoki J; Tagaya E; Matsumoto K; Morita H
Allergy; 2022 Mar; 77(3):843-855. PubMed ID: 34402091
[TBL] [Abstract][Full Text] [Related]
2. Blocking CD226 regulates type 2 innate lymphoid cell effector function and alleviates airway hyperreactivity.
Sakano Y; Sakano K; Hurrell BP; Helou DG; Shafiei-Jahani P; Kazemi MH; Li X; Shen S; Hilser JR; Hartiala JA; Allayee H; Barbers R; Akbari O
J Allergy Clin Immunol; 2024 May; 153(5):1406-1422.e6. PubMed ID: 38244725
[TBL] [Abstract][Full Text] [Related]
3. Severe asthma ILC2s demonstrate enhanced proliferation that is modified by biologics.
Malik B; Bartlett NW; Upham JW; Nichol KS; Harrington J; Wark PAB
Respirology; 2023 Aug; 28(8):758-766. PubMed ID: 37114915
[TBL] [Abstract][Full Text] [Related]
4. HTR2A agonists play a therapeutic role by restricting ILC2 activation in papain-induced lung inflammation.
Wang Z; Yan C; Du Q; Huang Y; Li X; Zeng D; Mao R; Gurram RK; Cheng S; Gu W; Zhu L; Fan W; Ma L; Ling Z; Qiu J; Li D; Liu E; Zhang Y; Fang Y; Zhu J; Sun B
Cell Mol Immunol; 2023 Apr; 20(4):404-418. PubMed ID: 36823235
[TBL] [Abstract][Full Text] [Related]
5. A novel type-2 innate lymphoid cell-based immunotherapy for cancer.
Saranchova I; Xia CW; Besoiu S; Finkel PL; Ellis SLS; Kari S; Munro L; Pfeifer CG; Fazli L; Gleave ME; Jefferies WA
Front Immunol; 2024; 15():1317522. PubMed ID: 38524132
[TBL] [Abstract][Full Text] [Related]
6. JAK3 inhibitor suppresses multipotent ILC2s and attenuates steroid-resistant asthma.
Kim J; Ham J; Kang HR; Bae YS; Kim T; Kim HY
Sci Adv; 2023 Dec; 9(51):eadi3770. PubMed ID: 38117887
[TBL] [Abstract][Full Text] [Related]
7. Cutting Edge: CCR8 Signaling Regulates IL-25- and IL-33-Responsive Skin Group 2 Innate Lymphoid Cell Migration and Function.
Sun Z; Sen H; Zhu X; Islam SA
J Immunol; 2023 Dec; 211(12):1751-1755. PubMed ID: 37921466
[TBL] [Abstract][Full Text] [Related]
8. NRP1 downregulation correlates with enhanced ILC2 responses during IL-33 challenge.
Wang Y; Liu G; Wang J; Zhou P; Zhang L; Liu Q; Zhou J
Immunology; 2024 Jun; 172(2):226-234. PubMed ID: 38409805
[TBL] [Abstract][Full Text] [Related]
9. Piezo1 channels restrain ILC2s and regulate the development of airway hyperreactivity.
Hurrell BP; Shen S; Li X; Sakano Y; Kazemi MH; Quach C; Shafiei-Jahani P; Sakano K; Ghiasi H; Akbari O
J Exp Med; 2024 May; 221(5):. PubMed ID: 38530239
[TBL] [Abstract][Full Text] [Related]
10. Combination of IL-33 with PD-1 blockade augment mILC2s-mediated anti-tumor immunity.
Yue J; Guo H; Xu P; Ma J; Shi W; Wu Y
Cancer Immunol Immunother; 2024 Mar; 73(4):65. PubMed ID: 38430390
[TBL] [Abstract][Full Text] [Related]
11. PD-1 pathway regulates ILC2 metabolism and PD-1 agonist treatment ameliorates airway hyperreactivity.
Helou DG; Shafiei-Jahani P; Lo R; Howard E; Hurrell BP; Galle-Treger L; Painter JD; Lewis G; Soroosh P; Sharpe AH; Akbari O
Nat Commun; 2020 Aug; 11(1):3998. PubMed ID: 32778730
[TBL] [Abstract][Full Text] [Related]
12. Monitoring Cellular Movement with Photoconvertible Fluorescent Protein and Single-Cell RNA Sequencing Reveals Cutaneous Group 2 Innate Lymphoid Cell Subtypes, Circulating ILC2 and Skin-Resident ILC2.
Nakatani-Kusakabe M; Yasuda K; Tomura M; Nagai M; Yamanishi K; Kuroda E; Kanazawa N; Imai Y
JID Innov; 2021 Sep; 1(3):100035. PubMed ID: 34909732
[TBL] [Abstract][Full Text] [Related]
13. New insights into ILC2 memory.
Martinez-Gonzalez I; Takei F
Immunol Rev; 2024 May; 323(1):118-125. PubMed ID: 38506432
[TBL] [Abstract][Full Text] [Related]
14. Involvement of Janus kinase-dependent Bcl-xL overexpression in steroid resistance of group 2 innate lymphoid cells in asthma.
Shimora H; Matsuda M; Nakayama Y; Maeyama H; Tanioka R; Tanaka Y; Kitatani K; Nabe T
Immunology; 2024 May; ():. PubMed ID: 38786548
[TBL] [Abstract][Full Text] [Related]
15. Type 2 innate lymphoid cells are not involved in mouse bladder tumor development.
Schneider AK; Domingos-Pereira S; Cesson V; Polak L; Fallon PG; Zhu J; Roth B; Nardelli-Haefliger D; Derré L
Front Immunol; 2023; 14():1335326. PubMed ID: 38283350
[TBL] [Abstract][Full Text] [Related]
16. Obesity correlates with the immunosuppressive ILC2s-MDSCs axis in advanced breast cancer.
Liu W; Li B; Liu D; Zhao B; Sun G; Ding J
Immun Inflamm Dis; 2024 Mar; 12(3):e1196. PubMed ID: 38501542
[TBL] [Abstract][Full Text] [Related]
17. [CGRP inhibits proliferation, activation and cytokine secretion of group 2 innate lymphoid cells (ILC2) in peripheral blood from patients with allergic rhinitis].
Zhuo H; Qi X; Xu N; Wang Y; An Y; Xue J; Zhao C
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Dec; 39(12):1094-1099. PubMed ID: 38140869
[TBL] [Abstract][Full Text] [Related]
18. UHPLC/MS-based metabolomics of asthmatic mice reveals metabolic changes in group 2 innate lymphoid cells.
Tang M; Da X; Xu Z; Zhao X; Zhou H
Int Immunopharmacol; 2024 Mar; 130():111775. PubMed ID: 38430805
[TBL] [Abstract][Full Text] [Related]
19. Iron controls the development of airway hyperreactivity by regulating ILC2 metabolism and effector function.
Hurrell BP; Sakano Y; Shen S; Helou DG; Li M; Shafiei-Jahani P; Kazemi MH; Sakano K; Li X; Quach C; Barbers R; Akbari O
Sci Transl Med; 2024 May; 16(746):eadk4728. PubMed ID: 38718131
[TBL] [Abstract][Full Text] [Related]
20. Plasticity between type 2 innate lymphoid cell subsets and amphiregulin expression regulates epithelial repair in biliary atresia.
Russi AE; Shivakumar P; Luo Z; Bezerra JA
Hepatology; 2023 Oct; 78(4):1035-1049. PubMed ID: 37078450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
